| Ms Lana Louise Andersen, CRNFA | |
|
1802 W El Caminito Dr, Phoenix, AZ 85021-5257 | |
| (602) 942-6166 | |
| (602) 942-6188 |
| Full Name | Ms Lana Louise Andersen |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Perioperative |
| Location | 1802 W El Caminito Dr, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588643084 | NPI | - | NPPES |
| 381707 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP2800X | Clinical Nurse Specialist - Perioperative | RN050320 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lana Louise Andersen, CRNFA Po Box 39482, Phoenix, AZ 85069-9482 Ph: (602) 942-6166 | Ms Lana Louise Andersen, CRNFA 1802 W El Caminito Dr, Phoenix, AZ 85021-5257 Ph: (602) 942-6166 |
News Archive
Varian Medical Systems has received FDA 510(k) clearance for the Acuros® XB advanced dose calculation algorithm which can complete a RapidArc® treatment plan two to three times faster than conventional planning algorithms. Varian has incorporated the Acuros algorithm for external beam radiotherapy treatment planning into its market-leading Eclipse™ treatment planning system on exhibit at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego October 31 - November 4.
Seattle Genetics, Inc. today announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas.
Small cell lung cancer is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy. The research group headed by Gerhard Hamilton, University Department of Surgery at MedUni Vienna, has now managed to identify the reason for this chemoresistance.
The 47th ERA-EDTA/DGfN congress in Munich has been the setting for a wide range of new clinical data. The results of the following clinical trials were presented at "Late-Breaking Clinical Trials Sessions."
› Verified 8 days ago
Kassandra Hyde, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-3962 | |
Lara Shleef, PA Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 750 E Thunderbird Rd Ste 1-3, Phoenix, AZ 85022 Phone: 602-682-7455 Fax: 602-218-6383 | |
Cathleen Murphy-taylor, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-509-6914 | |
Katie Marie Williams, CRNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4545 E Shea Blvd, 175, Phoenix, AZ 85028 Phone: 866-662-4560 Fax: 877-561-7566 | |
Mrs. Frances Marie Hanumaiah, ACNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 | |
Emily Jacobs, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1747 E Northern Ave Unit 256, Phoenix, AZ 85020 Phone: 734-604-6014 | |
Ms. Patricia Kate Paradis, FNP-C Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 10046 N Metro Pkwy W, Suite 115, Phoenix, AZ 85051 Phone: 602-674-5515 |